Could less chemo be better for brain lymphoma? major trial seeks answers
Disease control
Ongoing
This study tests whether a reduced-intensity chemotherapy regimen works better than the standard treatment for people newly diagnosed with primary CNS lymphoma, a rare brain cancer. About 331 adults aged 18 to 70 will receive either the standard MATRix protocol or a milder versio…
Phase: PHASE3 • Sponsor: Klinikum Stuttgart • Aim: Disease control
Last updated May 13, 2026 16:02 UTC